> [Go to French version](/fr/Règlements/Décrets,%20ordonnances%20et%20règlements%20statutaires/2016/231.md)

# Cannabis Exemption (Food and Drugs Act) Regulations

**SOR/2016-231**

Enabling authorities: 
- [FOOD AND DRUGS ACT](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-27.md)

Date registered: 5 August 2016

----------

His Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to paragraph 30(1)(j) of the [Food and Drugs Act](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-27.md)<sup><a href='#fn_a'>[a]</a></sup>, makes the annexed Cannabis Exemption (Food and Drugs Act) Regulations.

<a name='fn_a'><sup>a</sup></a>: R.S., c. F-27<br />




## Definitions



**Exemption**

**1** Cannabis, as defined in subsection 2(1) of the [Cannabis Act](/en/Acts/Statutes%20of%20Canada/2018/c.%2016.md) and in relation to which an activity is conducted in accordance with the [Cannabis Act](/en/Acts/Statutes%20of%20Canada/2018/c.%2016.md), is exempt from the application of the [Food and Drugs Act](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-27.md), unless the cannabis
- **(a)** is manufactured, sold or represented for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, or in restoring or correcting organic functions, in human beings or animals;
- **(b)** is represented for use in modifying organic functions in human beings or animals;
- **(c)** is manufactured, sold or represented for use in disinfection in premises in which food is manufactured, prepared or kept;
- **(d)** is an active pharmaceutical ingredient as defined in subsection C.01A.001(1) of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md);
- **(e)** is a food or a cosmetic that does not contain cannabis other than a derivative, or a product made from that derivative, that is exempt from the application of the [Cannabis Act](/en/Acts/Statutes%20of%20Canada/2018/c.%2016.md) under the [Industrial Hemp Regulations](/en/Regulations/Statutory%20Orders%20and%20Regulations/2018/145.md); or
- **(f)** is sold to be used for the purpose of a clinical trial, as defined in section C.05.001 of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md), or an experimental study, as defined in section C.08.013 of those Regulations.
> SOR/2018-144, s. 373





**Cannabis for medical purposes**

**2** Despite paragraph 1(a), cannabis that is manufactured or sold in accordance with the [Cannabis Regulations](/en/Regulations/Statutory%20Orders%20and%20Regulations/2018/144.md) is exempt from the application of the [Food and Drugs Act](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-27.md) from the time it is manufactured or sold by any of the following persons, unless it is represented for a use referred to in that paragraph:
- **(a)** a person to which a licence, other than a cannabis drug licence, was issued under subsection 62(1) of the [Cannabis Act](/en/Acts/Statutes%20of%20Canada/2018/c.%2016.md); and
- **(b)** a designated person as defined in Part 14 of the [Cannabis Regulations](/en/Regulations/Statutory%20Orders%20and%20Regulations/2018/144.md).
> SOR/2018-144, s. 373




**3** [Repealed, SOR/2018-144, s. 373]




## Repeal


**4** [Repeal]




## Coming into Force



**August 24, 2016**

**5** These Regulations come into force on August 24, 2016.


